Get the Stockscreener App
4.71
3.68%
-0.18
After Hours:
4.71
BiomX Inc stock is traded at $4.71, with a volume of 85,491.
It is down -3.68% in the last 24 hours and up +3.06% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$4.89
Open:
$4.85
24h Volume:
85,491
Relative Volume:
0.10
Market Cap:
$7.51M
Revenue:
-
Net Income/Loss:
$-36.20M
P/E Ratio:
-0.1973
EPS:
-23.8772
Net Cash Flow:
$-26.39M
1W Performance:
-5.42%
1M Performance:
+3.06%
6M Performance:
-52.60%
1Y Performance:
-52.35%
1-Day Range:
$4.66
$5.00
1-Week Range:
$4.54
$5.15
52-Week Range:
$1.5004
$14.71
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
4.71 | 7.79M | 0 | -36.20M | -26.39M | -23.88 |
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
692.83 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
BiomX (PHGE) Launches Subsidiary for Advanced Firefighting Solutions - GuruFocus
BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations - The Globe and Mail
BiomX puts $3M into Israel unit for firefighting drone rights - Stock Titan
BiomX (NYSE: PHGE) proposes 2026 equity plan with 1.39M shares and 4% evergreen - Stock Titan
What is BiomX Incs 5 year growth outlookWeekly Earnings Recap & Technical Confirmation Trade Alerts - baoquankhu1.vn
If You Invested $1,000 in Biomx Inc (PHGE) - Stock Titan
Market Catalysts: Will BiomX Inc outperform its industry peersInsider Selling & Precise Trade Entry Recommendations - baoquankhu1.vn
Layoff Tracker: Gossamer, BiomX Reveal Hefty Staff Cuts - BioSpace
BiomX amends warrants to one-year term, evaluates repositioning By Investing.com - Investing.com India
BiomX issues letter to shareholders - TipRanks
BiomX (PHGE) Restructures for Stronger Financial Future - GuruFocus
BiomX Details Financial Stabilization and Strategic Repositioning Plans - TipRanks
BiomX amends warrants to one-year term, evaluates repositioning - Investing.com
BiomX Cuts Warrant Strike to $1, Sets 2026 Expiry on 3.3M-Share Instrument - TradingView
BiomX (NYSE: PHGE) shortens warrant term and explores tech pivot - Stock Titan
BiomX CEO Issues Letter to Stockholders - marketscreener.com
Biomx Insider Sold Shares Worth $4,900,000, According to a Recent SEC Filing - marketscreener.com
BiomX (PHGE) director-linked LLC sells common shares and warrants - Stock Titan
Aug Technicals: Is BiomX Inc a cyclical or defensive stock2026 Update & High Accuracy Investment Signals - baoquankhu1.vn
Bidas Liat Cohavi Net Worth (2026) - GuruFocus
Stock Market Recap: Can BiomX Inc outperform in the next rallyJobs Report & Weekly Breakout Stock Alerts - baoquankhu1.vn
PHGE SEC FilingsBiomx Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BiomX appoints Michael Oster CEO, David Rokach CFO - Investing.com Nigeria
BiomX (PHGE) 10% owner’s entity converts preferred and sells 670,000 shares - Stock Titan
Aug Selloffs: Is BiomX Inc gaining market shareEarnings Overview Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn
BiomX Shareholders Approve Expanded Common Stock Issuance Authorization - The Globe and Mail
Breakouts Watch: Why is BiomX Inc stock going up2026 Volatility Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
BiomX Inc. Files Form 8-K Current Report with SEC – Company Details, Stock Symbol PHGE, and NYSE American Listing - Minichart
Gap Down: Why is BiomX Inc stock going upMarket Risk Report & AI Forecasted Entry and Exit Points - baoquankhu1.vn
BiomX Inc. (PHGE) stockholders back all proposals at March 11, 2026 special meeting - Stock Titan
Biomx Inc. Appoints Alex Wong as Chief Information Technology Officerfor Hong Kong and Macau - marketscreener.com
BiomX appoints Michael Oster CEO, David Rokach CFO By Investing.com - Investing.com Canada
BiomX (PHGE) Appoints New CEO and CFO to Strengthen Leadership T - GuruFocus
BiomX names Michael Oster as CEO, David Rokach as CFO - TipRanks
BiomX downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
PHGE: BiomX Downgraded to Neutral by HC Wainwright & Co. | PHGE Stock News - GuruFocus
H.C. Wainwright downgrades BiomX stock rating to neutral By Investing.com - Investing.com Australia
H.C. Wainwright downgrades BiomX stock rating to neutral - Investing.com
BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth - weeklyvoice.com
BiomX Inc. Appoints Michael Oster as Chief Executive Officer - marketscreener.com
Sentiment Watch: Is BiomX Inc a strong candidate for buy and holdEarnings Recap Report & Growth Focused Stock Reports - baoquankhu1.vn
Breakout Move: Can BiomX Inc outperform in the next rally2026 Major Catalysts & Fast Moving Trade Plans - baoquankhu1.vn
BiomX announces CEO and board changes, appoints Michael Oster as chief executive - Investing.com Australia
Can BiomX Inc. stock deliver strong Q4 earningsWeekly Market Summary & Daily Entry Point Trade Alerts - Naître et grandir
Aug Final Week: Can BiomX Inc maintain sales growthJuly 2025 Institutional & Breakout Confirmation Trade Signals - baoquankhu1.vn
BiomX (PHGE) taps Michael Oster as CEO as Solomon and chair exit - Stock Titan
Biomx IncJonathan Solomon resigns as CEO and board member effective March 4, 2026SEC filing - marketscreener.com
PHGE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
[Form 3] BiomX Inc. Initial Statement of Beneficial Ownership - Stock Titan
BiomX Inc. Announces Management Changes - marketscreener.com
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):